9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs

9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs

MPJE Core Concept: Whether a dispensed drug can be taken back and given to another patient is one of the most tested "return and reuse" scenarios. The default federal and state rule is no—once a drug leaves the pharmacy in the patient's hands, broken chain-of-custody and unknown storage make it suspect for adulteration and misbranding. Controlled substances are categorically barred from redispensing. Narrow exceptions (restocking never-dispensed prescriptions, sealed unit-dose returns from licensed facilities, and state donation/repository programs) exist but require strict conditions.

---

1. The Default Rule: No Redispensing of Patient-Returned Drugs

After a prescription drug has been dispensed and handed to the patient (or the patient's agent), it has left the pharmacy's control. The pharmacy cannot verify that the drug was stored at the proper temperature, was not tampered with, was not contaminated, and was not swapped. Reintroducing such a product to stock for redispensing risks dispensing an adulterated (degraded or contaminated) or misbranded (not in its original labeling) drug under the FD&C Act. Accordingly, most state pharmacy practice acts prohibit accepting a returned dispensed drug for redispensing, and NABP's position paper on return-and-reuse programs states that such programs are contrary to most, if not all, state practice acts unless expressly authorized by the board of pharmacy.

Practical consequence: many community pharmacies adopt a no-return policy on dispensed prescription drugs (other than internally handled recall or error corrections) precisely because lawful reuse is so narrow.

---

2. Controlled Substances: Absolute Federal Prohibition

For controlled substances the federal rule is stricter. A controlled substance dispensed to a patient cannot be redispensed to anyone else. Federal law prohibits transferring a controlled substance to any person other than the one for whom it was prescribed; once dispensed, the controlled substance is the patient's property. Therefore:

• A returned controlled substance may not re-enter pharmacy inventory.
• Unwanted or abandoned controlled substances must be destroyed—typically surrendered to a DEA-authorized collector (a pharmacy registered with DEA as a collector that maintains a secure take-back receptacle) or transferred to a DEA-registered reverse distributor for destruction.
• Drugs accepted at a take-back receptacle are collected for disposal only; they may not be redispensed or returned for cash or credit.
• In long-term-care or hospital settings, abandoned patient controlled substances (for example, a deceased patient's medications that cannot be returned) must be disposed of under DEA guidance, often with law-enforcement or DEA Diversion Field Office involvement.

Exam trap: A patient asks to "return" an unused Schedule II opioid for credit or redispensing. The correct pharmacist action is to refuse redispensing and credit, and to offer disposal through a DEA-authorized collector or reverse distributor—never to return the controlled substance to stock.

---

3. Restocking (Return-to-Stock) of Never-Dispensed Prescriptions

This is different from a patient return. If a prescription was filled but never picked up or delivered to the patient (the drug never left the pharmacy), the pharmacy may generally return the product to stock, provided:

• The drug remained under the pharmacy's control in appropriate storage;
• The product's integrity and expiration dating are intact;
• The pharmacy reverses the prescription billing (and any third-party claim) within the payer- or state-required window, so the drug is not double-billed;
• The return-to-stock and the reason are documented, and any state limit on the number of times a single prescription may be filled or picked up is respected.

Some states limit return-to-stock to once per prescription or impose a deadline (for example, 14 days) after which the filled-but-unclaimed prescription must be returned to stock or destroyed. The key MPJE distinction: restocking concerns a drug the patient never received; reuse or redispensing concerns a drug the patient did receive and brought back. Only the former is generally lawful.

---

4. Narrow Reuse Exceptions: Sealed Unit-Dose & Donation/Repository Programs

Where state law allows reuse at all, NABP and most states require strict conditions, including that the returned product be in tamper-evident, bulk, unit-of-use, or unit-dose packaging that remains in the dispensing pharmacy's original packaging with intact labeling and expiration dating—typically arising when a licensed facility (such as a long-term-care pharmacy) returns sealed unit-dose medications that were never administered. Such programs usually require prior approval from the state board of pharmacy, which may demand proof that the returned product is safe for redispensing.

State prescription drug donation/repository programs (for example, Iowa's Prescription Drug Donation Repository, established 2005) authorize medical facilities and pharmacies to redispense qualifying donated drugs to low-income patients. Common features:

• Donations limited to sealed, unopened, non-controlled drugs within their expiration dating;
• Controlled substances are universally prohibited from donation and repository programs;
• The receiving program inspects, stores, and documents donated drugs under board-approved criteria;
• Donations often originate from long-term-care providers returning sealed unit-dose stock or from physician-office samples where state law permits sample donation.

---

5. MPJE Reasoning Pattern

1. Determine whether the drug ever left the pharmacy (restocking versus patient return).
2. If it is a controlled substance that was dispensed, the answer is no redispensing—route it to disposal via an authorized collector or reverse distributor.
3. If it is a non-controlled patient return, the default is no redispensing unless a specific state exception (sealed unit-dose, board-approved program, or repository) applies.
4. If the prescription was never picked up, restocking with billing reversal and documentation is the lawful path.
5. Always distinguish disposal-only take-back (no reuse, no credit) from reuse exceptions (narrow and state-authorized).

Bottom line: Patient-returned dispensed drugs are presumptively not redispensable; controlled substances are never redispensable; restocking applies only to never-dispensed fills; and reuse or repository programs are rare, state-authorized, and exclude controlled substances.